Insider · CIK 0001370348
Johnson Craig A
Reports to the SEC for 10 companies · EDMONTON
Transactions
50
Companies
10
Filings
9
CIK
0001370348
Forms 4 and 5
Insider transactions
| Date | Company | Value |
|---|---|---|
| 2026-06-04 | AUPHAurinia Pharmaceuticals Inc. · Director Stock Option (right to buy)A Award | — |
| 2026-01-30 | HRTXHERON THERAPEUTICS, INC. /DE/A Award | — |
| 2025-11-21 | AUPHAurinia Pharmaceuticals Inc.F Tax Payment | −$94.7K |
| 2025-05-16 | AUPHAurinia Pharmaceuticals Inc. · Director Stock Option (right to buy)A Award | — |
| 2025-01-31 | HRTXHERON THERAPEUTICS, INC. /DE/ · Stock Option (Right to Buy)A Award | — |
| 2025-01-31 | HRTXHERON THERAPEUTICS, INC. /DE/A Award | — |
| 2025-01-30 | HRTXHERON THERAPEUTICS, INC. /DE/A Award | — |
| 2025-01-30 | HRTXHERON THERAPEUTICS, INC. /DE/ · Stock Option (Right to Buy)A Award | +$62.1K |
| 2024-11-21 | AUPHAurinia Pharmaceuticals Inc.A Award | — |
| 2024-11-21 | AUPHAurinia Pharmaceuticals Inc. · Director Stock Option (right to buy)A Award | — |
| 2024-01-23 | Mirati Therapeutics, Inc.Option to Purchase Common StockD Disposition to Issuer | — |
| 2024-01-23 | Mirati Therapeutics, Inc.Option to Purchase Common StockD Disposition to Issuer | — |
| 2024-01-23 | Mirati Therapeutics, Inc.D Disposition to Issuer | — |
| 2024-01-23 | Mirati Therapeutics, Inc.Option to Purchase Common StockD Disposition to Issuer | — |
| 2024-01-23 | Mirati Therapeutics, Inc.Option to Purchase Common StockD Disposition to Issuer | — |
| 2024-01-23 | Mirati Therapeutics, Inc.D Disposition to Issuer | — |
| 2024-01-23 | Mirati Therapeutics, Inc.Option to Purchase Common StockD Disposition to Issuer | — |
| 2024-01-23 | Mirati Therapeutics, Inc.D Disposition to Issuer | — |
| 2024-01-19 | HRTXHERON THERAPEUTICS, INC. /DE/ · Stock Option (Right to Buy)A Award | — |
| 2024-01-19 | HRTXHERON THERAPEUTICS, INC. /DE/A Award | — |
| 2023-12-29 | Mirati Therapeutics, Inc.A Award | +$400K |
| 2023-01-20 | Mirati Therapeutics, Inc.Non Qualified Stock Option (right to buy)A Award | — |
| 2023-01-20 | Mirati Therapeutics, Inc.A Award | — |
| 2022-12-16 | HRTXHERON THERAPEUTICS, INC. /DE/ · Stock Option (Right to Buy)A Award | — |
| 2022-12-16 | HRTXHERON THERAPEUTICS, INC. /DE/A Award | — |
| 2022-08-22 | LA JOLLA PHARMACEUTICAL COStock Option (Right to Buy)D Disposition to Issuer | — |
| 2022-08-22 | LA JOLLA PHARMACEUTICAL COStock Option (Right to Buy)D Disposition to Issuer | — |
| 2022-08-22 | LA JOLLA PHARMACEUTICAL COStock Option (Right to Buy)D Disposition to Issuer | — |
| 2022-08-22 | LA JOLLA PHARMACEUTICAL COStock Option (Right to Buy)D Disposition to Issuer | — |
| 2022-08-22 | LA JOLLA PHARMACEUTICAL COStock Option (Right to Buy)D Disposition to Issuer | — |
| 2022-08-22 | LA JOLLA PHARMACEUTICAL COStock Option (Right to Buy)D Disposition to Issuer | — |
| 2022-08-22 | LA JOLLA PHARMACEUTICAL COD Disposition to Issuer | −$74.8K |
| 2022-08-22 | LA JOLLA PHARMACEUTICAL COStock Option (Right to Buy)D Disposition to Issuer | — |
| 2022-08-22 | LA JOLLA PHARMACEUTICAL COStock Option (Right to Buy)D Disposition to Issuer | — |
| 2022-08-22 | LA JOLLA PHARMACEUTICAL COStock Option (Right to Buy)D Disposition to Issuer | — |
| 2022-08-22 | LA JOLLA PHARMACEUTICAL COStock Option (Right to Buy)D Disposition to Issuer | — |
| 2022-07-08 | LA JOLLA PHARMACEUTICAL COEmployee Stock Option (Right to Buy)M Exercise/Conversion | — |
| 2022-07-08 | LA JOLLA PHARMACEUTICAL COM Exercise/Conversion | +$47.2K |
| 2022-01-14 | Mirati Therapeutics, Inc.Non Qualified Stock Option (right to buy)A Award | — |
| 2022-01-14 | Mirati Therapeutics, Inc.A Award | — |
| 2022-01-12 | LA JOLLA PHARMACEUTICAL COStock Option (Right to Buy)A Award | — |
| 2021-12-22 | HRTXHERON THERAPEUTICS, INC. /DE/ · Stock Option (Right to Buy)A Award | — |
| 2021-12-22 | HRTXHERON THERAPEUTICS, INC. /DE/A Award | — |
| 2021-12-21 | HRTXHERON THERAPEUTICS, INC. /DE/S Sale | −$2,431.925 |
| 2021-09-21 | HRTXHERON THERAPEUTICS, INC. /DE/S Sale | −$3,074.1 |
| 2021-06-21 | HRTXHERON THERAPEUTICS, INC. /DE/S Sale | −$3,800.6 |
| 2021-04-06 | HRTXHERON THERAPEUTICS, INC. /DE/S Sale | −$4,305.2 |
| 2021-01-21 | Mirati Therapeutics, Inc.M Exercise/Conversion | +$308K |
| 2021-01-21 | Mirati Therapeutics, Inc.Non Qualified Stock Option (right to buy)M Exercise/Conversion | — |
| 2021-01-21 | Mirati Therapeutics, Inc.S Sale | −$71.7K |
Recent filings
- 4Johnson Craig A0001370348-26-000002SEC(opens sec.gov)
- 4Johnson Craig A0001193125-26-034629SEC(opens sec.gov)
- 4Johnson Craig A0001370348-25-000004SEC(opens sec.gov)
- 4Johnson Craig A0001600620-25-000077SEC(opens sec.gov)
- 4/AJohnson Craig A0000950170-25-013756SEC(opens sec.gov)
- 4Johnson Craig A0000950170-25-012101SEC(opens sec.gov)
- 4Johnson Craig A0001600620-24-000122SEC(opens sec.gov)
- 4Johnson Craig A0001140361-24-003534SEC(opens sec.gov)
- 4Johnson Craig A0001209191-24-001979SEC(opens sec.gov)
Companies
- Ardea Biosciences, Inc./DEDirector
- Aurinia Pharmaceuticals Inc.DirectorAUPH
- DMK PHARMACEUTICALS CorpDirector
- HERON THERAPEUTICS, INC. /DE/DirectorHRTX
- HORIZON PHARMACEUTICAL LLCV.P. Finance, CFO & Secretary
- LA JOLLA PHARMACEUTICAL CODirector
- Mirati Therapeutics, Inc.Director
- NOVADEL PHARMA INCSr. VP, CFO and Secretary
- Odonate Therapeutics, Inc.Director
- PURE BIOSCIENCE, INC.Chief Financial OfficerPURE
Address
#140, 14315 - 118 AVENUE
EDMONTON, T5L 4S6